Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions: A joint statement by the european society of cardiology, the council on hypertension of the european society of cardiology, the european society of hypertension, the international society of mountain medicine, the Italian society of hypertension and the Italian society of mountain medicine

G. Parati, P. Agostoni, B. Basnyat, G. Bilo, H. Brugger, A. Coca, L. Festi, G. Giardini, A. Lironcurti, A.M. Luks, M. Maggiorini, P.A. Modesti, E.R. Swenson, B. Williams, P. Bärtsch, C. Torlasco

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1-11
Number of pages11
JournalEuropean Heart Journal
Issue number17
Publication statusPublished - 2018


  • acetazolamide
  • antithrombocytic agent
  • beta adrenergic receptor blocking agent
  • nebivolol
  • nifedipine
  • telmisartan
  • altitude
  • blood clotting
  • blood pressure
  • brain hemorrhage
  • brain ischemia
  • cardiovascular disease
  • congenital heart disease
  • coronary artery bypass graft
  • drug efficacy
  • environmental exposure
  • heart arrhythmia
  • heart failure
  • heart function
  • heart muscle revascularization
  • heart rate
  • human
  • hypertension
  • hypoxia
  • ischemic heart disease
  • lung artery pressure
  • lung function
  • lung ventilation
  • monotherapy
  • Note
  • physical activity
  • potassium intake
  • priority journal
  • pulmonary hypertension

Cite this